Detalhe da pesquisa
1.
Anticancer therapy within the last 30 days of life: results of an audit and re-audit cycle from an Australian regional cancer centre.
BMC Palliat Care
; 19(1): 14, 2020 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31987038
2.
Chemotherapy and biologic use in the routine management of metastatic colorectal cancer in Australia: is clinical practice following the evidence?
Intern Med J
; 49(4): 446-454, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30230679
3.
Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial.
Lancet Oncol
; 18(9): 1202-1210, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28729151
4.
Pembrolizumab Induced Ocular Hypotony With Near Complete Vision Loss, Interstitial Pulmonary Fibrosis and Arthritis.
Front Oncol
; 9: 944, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31608234
5.
Risk of febrile neutropenia and early treatment cessation in men receiving standard and dose-reduced 3-weekly docetaxel for metastatic castration-resistant prostate cancer.
Asia Pac J Clin Oncol
; 14(5): e399-e404, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29318740
6.
Outcomes for patients with synchronous and metachronous primary lung cancer after diagnosis of head and neck cancer.
Head Neck
; 39(8): 1544-1549, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28593651
7.
Efficacy and toxicity of PACEBOM chemotherapy in relapsed/refractory aggressive lymphoma in the rituximab era.
Asia Pac J Clin Oncol
; 13(3): 226-233, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28004881